Financials data is unavailable for this security.
View more
Year on year Touchstone International Medical Science Co Ltd grew revenues 9.31% from 232.03m to 253.65m while net income improved 9.53% from 43.20m to 47.31m.
Gross margin | 55.96% |
---|---|
Net profit margin | 20.78% |
Operating margin | 20.83% |
Return on assets | 9.05% |
---|---|
Return on equity | 10.13% |
Return on investment | 10.06% |
More ▼
Cash flow in CNYView more
In 2023, Touchstone International Medical Science Co Ltd increased its cash reserves by 540.00%, or 178.48m. Cash Flow from Investing totalled 97.97m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 82.95m in cash from operations while cash used for financing totalled 4.74m.
Cash flow per share | -- |
---|---|
Price/Cash flow per share | -- |
Book value per share | 7.05 |
---|---|
Tangible book value per share | 6.55 |
More ▼
Balance sheet in CNYView more
Current ratio | 5.19 |
---|---|
Quick ratio | 4.76 |
Total debt/total equity | 0.0028 |
---|---|
Total debt/total capital | 0.0028 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 14.37%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years) | 15.96 |
---|---|
EPS (TTM) vs TTM 1 year ago | 27.51 |